Exploitation of Indian health care industry is being aggressively focused
The global pharma industries who
are into the segment of life saving drug manufacturing are playing the game of
capitalisms and are busy in printing money rather than saving life. Being an
journalist I strongly resist on the issue. Anti-diversion programme this
is the law which is being used by the foreign pharma companies to play with
human life. This law acts in this fashion where the patients will only get the
drug if they can provide identification, proof of citizenship and residency. This will prevent many people from accessing the
drug as well as will create lot of problem for the patients who are busy
focusing on saving their loved ones. Many doctors will shy away from prescribing
and will create more rumors of non availability of the drug. Further drug mafia’s
will get a place to play indirectly as they have unlimited scales to reach anywhere. I find
that this Anti-diversion programme and the pressure on the Indian government
regarding IPR changes are being designed to increase the income inequality among
the Indians. Indians are increasing their wealth and are trying to increase the
GDP growth. In such condition restriction on drugs and medicines will create
massive problem at the ground levels which will lead to further problem for the
people in terms of macro factors. This will lead to widening of income inequality,
more deaths due to non affordability and also insurance companies will find a
substantial hit in the long term. Drugmakers and their lobby group
Pharmaceutical Research and Manufacturers of America (PhRMA) which have made
some of the strongest representations to the US government against India's IPR
regime.
Further its being found that
Indian government is being pressured and also many legal actions are being
floated against the Indian pharma companies so that the Indian IPR act could be
modified and could be modified where they can control the generic drug market.
They want decade of patent orders on their product which are highly priced and
also beyond common man reach. The Indian generic drug segment helps many
Indians to access medicines which becomes to their affordability. This is a
clear study of exploitation of resources in a
country like India where 60% of the population don’t have proper access to
health care facilities. Share holders profits and exponential growth is busy in
changing the landscape of the world. People will die but they will not get medicine
unless they are at the affordable levels hence these Anti-diversion programme
will create massive problems rather than solving. Just imagine that if in case
of polio this law have been adopted then imagine the condition of India and
other countries. Overseas foreign
companies are pressuring the Indian governments to adopt this law and also to
incorporate changes in the IPR act.
I find that Indian population is
being taken as a field of exploitation where in case of health. US have kept India
in high alert place due to IPR since they want changes. The same is applicable
in case of Europe. They want Indian markets to be controlled and make the
income inequality widen among Indians who are working hard to fill up the gap. US
drugmakers have three major problems with India's patent law - Section 3(d) and
Section 84 of the Indian Patents Act, and absence of a period of exclusive
marketing rights when a new drug gets regulatory approval. Under Section 3(d),
new forms of existing medicines can't be patented unless they improve
therapeutic efficacy. Section 84 allows issuing a compulsory licence to meet the
reasonable requirements of the public at a reasonably affordable price. A
compulsory license can also be granted under Section 92 of the Act in case of a
national emergency.